BioSig Technologies to commence trading on the Nasdaq
BioSig, a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology marketplace, announced that its shares of common stock have been approved for trading on the Nasdaq Capital Market. September 19, 2018